Geekwire: Researchers discover new avenue for fighting COVID-19, Ebola and other viral diseases
Read More
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
Read More
New biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI
Read more ➡
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology
Read More
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
Read More
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
Read More
Benaroya Research Institute awarded $5.8M from NIH for immunology-related COVID research
Read more ➡
Dr. Harrison Awarded First NOSTER Science Microbiome Prize
Read More
Benaroya Research Institute at Virginia Mason is a leader in finding cure to autoimmune diseases
Watch video ➡
Engineered T cells for type 1 diabetes move closer to clinic
Read more ➡
Gene-edited T cells to treat diabetes inch closer to clinical trials
Read more ➡
Are those ‘Covid toes,’ or should you be wearing slippers?
Read more ➡
Hybrid Insulin Peptides are Recognized by Human T Cells in the Context of DRB1*04:01
Read more ➡
Healing the Immune System: Autoimmune Breakthroughs Offer New Hope
Learn more ➡
